Reg D Scare Fading, But Medcap Sales Still Haunt A Broker-dealer

NOV 18, 2012
It appears that the private-placement debacle that swept through the independent-broker-dealer industry and forced dozens of small to midsize firms to close is finally over. It has been several months since InvestmentNews and other industry publications have covered the story in any meaningful way, and a certain amount of stability has returned to the marketplace. For firms that sold Medical Capital Holdings Inc. notes and survived — most notably Securities America Inc. — the litigation is over, and they can get back to business. But the picture for one broker-dealer isn't so clear. Hantz Financial Services Inc. is still dealing with the fallout from Medical Capital, the $2.2 billion Ponzi scheme built on shaky medical receivables that the Securities and Exchange Commission closed down in July 2009. According to InvestmentNews sister publication Crain's Detroit Business, Hantz still faces a potential class action over the sale of the notes. A judge in Michigan's Oakland County soon could decide on what may be a final attempt to certify the class of investors.

UNDER THE RADAR

The report — published Nov. 11, about Hantz's selling MedCap private placements to 300 clients — came as something of a surprise. A midsize firm with 260 affiliated advisers, Hantz had flown under the radar when it came to selling MedCap notes. According to the Crain's Detroit story, the remaining investors could have damage claims against the firm totaling more than $20 million. Hantz general counsel David Shea told Crain's Detroit that the firm stopped selling MedCap notes in 2008 after it learned that a previous series of notes had defaulted. Hantz also performed due diligence on the company and the notes, he said. In an interview last Monday, Mr. Shea said that the plaintiffs failed to certify a class action in another lawsuit in 2010. “It's in front of the same judge as before,” Mr. Shea said, adding that he is confident of a favorable outcome for Hantz. “You don't get a do-over.” The firm has settled with a couple of clients over the sale of the notes, but another client failed to win an award against Hantz in securities arbitration, Mr. Shea said. The firm didn't sell the final series, the disastrous MedCap VI, he added. MedCap is in receivership. Meanwhile, thousands of investors are waiting to find out if they will get any of their money returned. [email protected] Twitter: @bdnewsguy

Latest News

Brooklyn-based Maridea snaps up former LPL affiliate to expand in the Midwest
Brooklyn-based Maridea snaps up former LPL affiliate to expand in the Midwest

Maridea Wealth Management's deal in Chicago, Illinois is its first after securing a strategic investment in April.

Trump executive order set to ease path for private assets in 401(k)s, but hurdles remain
Trump executive order set to ease path for private assets in 401(k)s, but hurdles remain

A new PitchBook analysis unpacks sticking points relating to liquidity, costs, and litigation risk for would-be investors and plan sponsors.

Chuck Roberts, ex-star at Stifel, barred from the securities industry
Chuck Roberts, ex-star at Stifel, barred from the securities industry

"The outcome is correct, but it's disappointing that FINRA had ample opportunity to investigate the merits of clients' allegations in these claims, including the testimony in the three investor arbitrations with hearings," Jeff Erez, a plaintiff's attorney representing a large portion of the Stifel clients, said.

Vestmark, BlackRock, iCapital, and Dynasty forge four-way private market partnership
Vestmark, BlackRock, iCapital, and Dynasty forge four-way private market partnership

The collaboration will give RIAs yet another access point into the alternatives space through a new unified managed account capability.

DeVoe: Record-breaking RIA M&A run led by private equity's consolidator comeback
DeVoe: Record-breaking RIA M&A run led by private equity's consolidator comeback

A drop in interest rates and easier access to capital has reignited appetite among private equity-backed consolidators, who accounted for 53% of RIA deals so far this year- their highest share since 2021 according to DeVoe & Company.

SPONSORED How advisors can build for high-net-worth complexity

Orion's Tom Wilson on delivering coordinated, high-touch service in a world where returns alone no longer set you apart.

SPONSORED RILAs bring stability, growth during volatile markets

Barely a decade old, registered index-linked annuities have quickly surged in popularity, thanks to their unique blend of protection and growth potential—an appealing option for investors looking to chart a steadier course through today's choppy market waters, says Myles Lambert, Brighthouse Financial.